Literature DB >> 6665750

Comparison of three techniques of inhalation on the airway response to terbutaline.

M J Cushley, R A Lewis, A E Tattersfield.   

Abstract

The relative efficiency of the metered dose inhaler (MDI), the MDI attached to a pear shaped extension tube (PET), and the Inspiron Mini-Neb nebuliser were assessed in eight normal and eight asthmatic subjects. Subjects inhaled the same increasing doses of terbutaline with each technique on different occasions and the response was measured as specific airway conductance (sGaw) and, in the asthmatic patients only, as FEV1. The PET produced greater bronchodilatation than either the MDI or the nebuliser in both normal and asthmatic subjects. Serum terbutaline concentrations were similar after the PET and MDI in the normal subjects, but were lower with the PET in the asthmatic patients. The nebuliser produced about the same amount of bronchodilatation as the MDI--slightly less in the normal subjects and slightly more when assessed as FEV1 in the asthmatic subjects. Serum terbutaline concentrations were lower after the nebuliser than after the MDI in both groups of subjects. For patients with moderately severe airways obstruction requiring large doses of beta agonist, the nebuliser will produce an amount of bronchodilatation similar to the MDI with lower blood levels. Overall, the PET produced greater bronchodilatation than either of the other two methods of inhalation, with low serum terbutaline concentrations similar to those produced by the nebuliser in the asthmatic patients.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6665750      PMCID: PMC459695          DOI: 10.1136/thx.38.12.908

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  17 in total

1.  Comparison of two methods of administering bronchodilator aerosol to asthmatic patients.

Authors:  Y F Choo-Kang; I W Grant
Journal:  Br Med J       Date:  1975-04-19

2.  Use of pressurised aerosols by asthmatic patients.

Authors:  I C Paterson; G K Crompton
Journal:  Br Med J       Date:  1976-01-10

3.  Quantitative analysis of terbutaline in serum and urine at therapeutic levels using gas chromatography--mass spectrometry.

Authors:  J G Leferink; I Wagemaker-Engels; R A Maes
Journal:  J Chromatogr       Date:  1977-05-01

4.  Efficiency of nebulizers for depositing saline in human lung.

Authors:  T Asmundsson; R F Johnson; K H Kilburn; J K Goodrich
Journal:  Am Rev Respir Dis       Date:  1973-09

5.  Pharmacokinetics of inhaled substances.

Authors:  D S Davies
Journal:  Postgrad Med J       Date:  1975       Impact factor: 2.401

6.  Nebulised salbutamol in adult asthma.

Authors:  S J Connellan; R S Wilson
Journal:  Lancet       Date:  1978-03-25       Impact factor: 79.321

7.  Comparative efficacy of salbutamol by pressurized aerosol and wet nebulizer in acute asthma.

Authors:  R A Tarala; B W Madsen; J W Paterson
Journal:  Br J Clin Pharmacol       Date:  1980-10       Impact factor: 4.335

8.  Bronchodilating effect and side effects of beta2- adrenoceptor stimulants by different modes of administration (tablets, metered aerosol, and combinations thereof). A study with salbutamol in asthmatics.

Authors:  S Larsson; N Svedmyr
Journal:  Am Rev Respir Dis       Date:  1977-11

9.  A comparison of salbutamol given by pressure-packed aerosol or nebulization via IPPB in acute asthma.

Authors:  R M Cayton; B Webber; J W Paterson; T J Clark
Journal:  Br J Dis Chest       Date:  1978-07

10.  Comparison of infused and inhaled terbutaline in patients with asthma.

Authors:  G Thiringer; N Svedmyr
Journal:  Scand J Respir Dis       Date:  1976
View more
  19 in total

Review 1.  Inhaler devices for the treatment of asthma and chronic obstructive airways disease (COPD).

Authors:  J Wright; D Brocklebank; F Ram
Journal:  Qual Saf Health Care       Date:  2002-12

2.  Comparison of the extrapulmonary beta2-adrenoceptor responses and pharmacokinetics of salbutamol given by standard metered dose-inhaler and modified actuator device.

Authors:  D M Newnham; D G McDevitt; B J Lipworth
Journal:  Br J Clin Pharmacol       Date:  1993-11       Impact factor: 4.335

3.  Large volume plastic spacers in asthma.

Authors:  D Keeley
Journal:  BMJ       Date:  1992-09-12

4.  Determination of the relative bioavailability of salbutamol to the lungs and systemic circulation following nebulization.

Authors:  V L Silkstone; S A Corlett; H Chrystyn
Journal:  Br J Clin Pharmacol       Date:  2002-08       Impact factor: 4.335

5.  Drug delivery from holding chambers with attached facemask.

Authors:  M L Everard; A R Clark; A D Milner
Journal:  Arch Dis Child       Date:  1992-05       Impact factor: 3.791

6.  Early lung absorption profile of non-CFC salbutamol via small and large volume plastic spacer devices.

Authors:  B J Lipworth; D J Clark
Journal:  Br J Clin Pharmacol       Date:  1998-07       Impact factor: 4.335

7.  Systemic beta-adrenoceptor responses to salbutamol given by metered-dose inhaler alone and with pear shaped spacer attachment: comparison of electrocardiographic, hypokalaemic and haemodynamic effects.

Authors:  B J Lipworth; D G McDevitt; A D Struthers
Journal:  Br J Clin Pharmacol       Date:  1989-06       Impact factor: 4.335

8.  Inhalation treatment for asthma.

Authors:  J Reiser; J O Warner
Journal:  Arch Dis Child       Date:  1986-01       Impact factor: 3.791

9.  Which inhaler is best?

Authors:  B Holmes
Journal:  J R Soc Med       Date:  1989-02       Impact factor: 5.344

Review 10.  Therapeutic aerosols 2--Drugs available by the inhaled route.

Authors:  S W Clarke; S P Newman
Journal:  Thorax       Date:  1984-01       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.